Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1233088.RAaZdY-btX_6PDSmK-7Ayrmr4zHPYnfTodnw2IA9C51hk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1233088.RAaZdY-btX_6PDSmK-7Ayrmr4zHPYnfTodnw2IA9C51hk130_assertion type Assertion NP1233088.RAaZdY-btX_6PDSmK-7Ayrmr4zHPYnfTodnw2IA9C51hk130_head.
- NP1233088.RAaZdY-btX_6PDSmK-7Ayrmr4zHPYnfTodnw2IA9C51hk130_assertion description "[Alterations in the phosphoinositide 3-kinase/AKT/mammalian target of rapamycin (PI3K/AKT/mTOR) signalling pathway are frequent in urothelial bladder cancer (BLCA) and thus provide a potential target for novel therapeutic strategies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1233088.RAaZdY-btX_6PDSmK-7Ayrmr4zHPYnfTodnw2IA9C51hk130_provenance.
- NP1233088.RAaZdY-btX_6PDSmK-7Ayrmr4zHPYnfTodnw2IA9C51hk130_assertion evidence source_evidence_literature NP1233088.RAaZdY-btX_6PDSmK-7Ayrmr4zHPYnfTodnw2IA9C51hk130_provenance.
- NP1233088.RAaZdY-btX_6PDSmK-7Ayrmr4zHPYnfTodnw2IA9C51hk130_assertion SIO_000772 25349966 NP1233088.RAaZdY-btX_6PDSmK-7Ayrmr4zHPYnfTodnw2IA9C51hk130_provenance.
- NP1233088.RAaZdY-btX_6PDSmK-7Ayrmr4zHPYnfTodnw2IA9C51hk130_assertion wasDerivedFrom befree-2016 NP1233088.RAaZdY-btX_6PDSmK-7Ayrmr4zHPYnfTodnw2IA9C51hk130_provenance.
- NP1233088.RAaZdY-btX_6PDSmK-7Ayrmr4zHPYnfTodnw2IA9C51hk130_assertion wasGeneratedBy ECO_0000203 NP1233088.RAaZdY-btX_6PDSmK-7Ayrmr4zHPYnfTodnw2IA9C51hk130_provenance.